Senior insider sale
EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC — senior position signals high conviction
$558.6K
9.61K shares
What this filing means
FRIBERG GREGORY R plans to sell 9.61K shares of BIOMARIN PHARMACEUTICAL INC valued at approximately $558.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/7/2026ACC: 0001959173-26-003374
Officer· EVP, Chief R&D Officer
Since Feb 2026
9.61K
Shares to sell
$558.6K
Approx. market value
3.28K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months2
ESPP Purchase
Cash
4/30/2026
473.00Restricted Stock Vesting
Compensation
3/17/2026
2.81KTotal acquired3.28K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/30/2026 | ESPP Purchase Cash | 473.00 | — |
3/17/2026 | Restricted Stock Vesting Compensation | 2.81K | — |
| Total | 3.28K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
6.33K
Market value
$381.9K
2/26/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.28K
Market value
$176.7K
5/7/2026
Total
Units
9.61K
Value
$558.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/26/2026 | 6.33K | $381.9K | — | Completed |
| Planned — Approximate Date | ||||
5/7/2026 | 3.28K | $176.7K | NASDAQ | Planned |
| Total | 9.61K | $558.6K | ||